Pharmacogenomics

caja farma 2 P

 

Pharmacogenetics, or Pharmacogenomics, studies our predisposition to drugs. Thanks to this DNA analysis we can ascertain whether one is predisposed to a drug that might be toxic to him, or that has little effect, or too much, and much more.

We have always observed how some drugs have the desired effect on some people, but not on others. There may be many causes that explain these differences, and pharmacogenetics is undoubtedly one of the most important factors.

The Mayo Clinic and Pharmacogenomics: Click here to see the video

Our DNA analysis of pharmacogenetics analyses a list of medicines from our genetic map. We operate based on recognised scientific studies widely accepted by the scientific community, to which we apply your genetic data. Checking your genetic data against these studies, our algorithms show us your predisposition to these drugs.

Personalized medicine

There is more and more talk today about personalised medicine or precision medicine. Pharmacogenetics is the first step towards individualised medicine, no longer prescribed in an industrialised way. Thanks to it the wrong drugs are no longer prescribed because, with the patient’s genetic data available, we know that they are not the most appropriate for us.

In this new era of personalised medicine, each person has prescribed drugs based on his individual profile, because no two people are the same, and different drugs have different effects on each person. Thanks to DNA analysis of pharmacogenomics, we can confirm your predisposition to several drugs, so that doctors can avoid those that we know it is very likely will produce toxicity, or that simply will not have the desired effect. Thus, doctors will be able to choose the drugs that best suit their patients, and calculate doses in a much smarter way.

caja farma 2 P

Buy now

(Pharmacogenomics Plus not available in the USA)

Personalised medicine is, at the same time, a fundamental element for reducing costs (and time) for healthcare systems, because the "let's try this medication and if it does not work we'll change it" approach is consistently avoided.

There are medications with which, once prescribed, it takes months to evaluate whether they are having the desired effect or not. In many cases, for the same pathology there are different pharmacological alternatives, and your doctor, having your pharmacological report, will be more likely to get it right.

Our pharmacogenetic report is divided into 5 specialised medical fields: Cardiology, Neurology, Pain, Oncology, and others.

 

Download an example of our Pharmacogenomics report here

pharmacogenomics report

Reports available in English, German, French, Italian and Spanish. 

 

These are some of the drugs that we analyze for:

 

Area Drug
Cardiology Phenprocoumon
Cardiology Hydrochlorothiazide
Cardiology Pravastatin
Cardiology Simvastatin
Cardiology Warfarin
Neurology Amisulpride
Neurology Amitriptyline
Neurology Antidepressants
Neurology Aripiprazole
Neurology Bupropion
Neurology Carbamazepine
Neurology Citalopram
Neurology Clomipramine
Neurology Clozapine
Neurology Escitalopram
Neurology Haloperidol
Neurology Olanzapine
Neurology Paliperidone
Neurology Quetiapine
Neurology Risperidone
Neurology Ziprasidone
Pain Alfentanil 
Pain Aspirin
Pain Buprenorphine 
Pain Fentanyl
Pain Meperidine
Pain Morphine
Pain Naltrexone
Pain Pentazocine
Pain Tramadol
Oncology Cisplatin
Oncology Fluorouracil, capecitabine, pyrimidine analogs, tegafur, and Neoplasms
Oncology Irinotecan
Oncology Mercaptopurine
Oncology Methotrexate
Oncology Tamoxifen
Oncology Vincristine
Other Peginterferon Alpha-2b
Other Ribavirin 
Other Tacrolimus
Other Viagra (Sildenafil)


This report is not valid for clinical or diagnostic use

 

caja farma 2 P

Buy now

(Pharmacogenomics Plus not available in the USA)

DNA Internationa

×

Log in